Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Teamwork tackles back pain: new study tests coordinated care

NCT ID NCT05531201

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a coordinated care plan between general practitioners and physiotherapists can reduce disability in adults with chronic low back pain or those at risk of developing it. About 123 participants will be followed for 12 months. The goal is to see if better communication and teamwork among healthcare providers leads to less pain-related disability and improved quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

123 people

The number who actually took part.

Started

Feb 2023

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adult patients between the ages of 18 and 65 * Patients consulting their GP for a first or new eisode of acute low back pain (more than 12 months from the previous one) with a STarT Back screening tool score greater than 3. * OR low back pain at risk of chronicity (presence of yellow flags, according to the recommendation of the High Health Authority (HAS) of 2019 * OR recurrent low back pain: in the event of recurrence of low back pain within 12 months after the previous episode, then considered to be at risk of chronicity * OR having chronic low back pain (low back pain for more than 3 months) * Patients benefiting from the general social security system * Patients who understand and speak French fluently * Patients who have given their consent after having received complete information on the protocol Exclusion Criteria: * Minor patients * Pregnant women (declared pregnancy) or immediately postpartum (up to 3 months) * Patients with "red flags" (serious neurological impairment, cancer, infection, fracture or inflammatory disease), according to the 2019 HAS recommendation * Patients referred immediately for imaging or specialist advice during the first consultation with the GP (suspicion of underlying pathology) * Patients with no history of acute low back pain, at low risk of chronicity (STarT Back screening tool score less than or equal to 3) * Patients with a contraindication to rehabilitation by physiotherapy * Patients who have already undergone spine surgery * Patients with cognitive impairment * Patients whose life expectancy is less than 12 months * Patients under guardianship or curatorship, under judicial protection or safeguard of justice * Patients not affiliated to the general social security system * Patients with difficulties in understanding the French language * Patients with an inability to give express consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low back pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Maison de Santé Pluriprofessionnelle Universitaire

    Fontainebleau, 77300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.